PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26024F0325Fluarix — Glaxosmithkline, LLC

Glaxosmithkline, LLC holds $3.0B across 194 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 36E79724D0005. PoP ended Dec 31, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)

Awarding office

Glaxosmithkline, LLC

Recipient

Dec 31, 2024

PoP end

$108K

Obligated

$108K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Glaxosmithkline, LLC — $90

Contract facts

Federal

Contract number36C26024F0325

Also listed as36C260-24-F-0325

Also listed as36E79724D0005-36C26024F0325

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentGlaxosmithkline, LLC

CAGE667E9

UEIFRHTPHMZMX47

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36E79724D0005

Place of performanceDURHAM NC

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMar 28, 2024

PoP end (current)Dec 31, 2024

Obligated$108K

Current value$108K

Potential value$108K

FLUARIX is a federal award for 260-Network Contract Office 20 (36C260) held by Glaxosmithkline, LLC. Estimated value $108K ($108K obligated). Current period of performance ends Dec 31, 2024. Place of performance: DURHAM NC.

Recompete timing

Public

● Past PoP end (599 days ago)

Current PoP ended Dec 31, 2024 (599 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Glaxosmithkline, LLC — $3.0B obligated across 194 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.0B) · all agencies

Department of Health and Human Services (HHS)$3.0B · 100%Department of Defense (DOD)$1.7M · 0%Department of Veterans Affairs (VA)$1.5M · 0%Department of State (DOS)$1.2M · 0%

Open full company profile →

Related awards

Same parent · incumbent

75A50125F61019

FILL/FINISH DOD AS03 ADJUVANT CLIN 1006E

$491K

Aug 30, 2026

75A50126F61020

TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIOR…

$493K

Oct 29, 2026

15F06724F0001366

GSK TRAVEL VACCINES

$115K

Dec 31, 2026

15F06726F0000234

GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187

$105K

Dec 31, 2026

75A50124F61014

THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL …

$18.4M

Feb 21, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26024F0325?

36C26024F0325 (Fluarix) is a 260-Network Contract Office 20 (36C260) award with a potential value of $108K, currently held by Glaxosmithkline, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-24-F-0325?

36C260-24-F-0325 is the dashed form of PIID 36C26024F0325 (Fluarix), held by Glaxosmithkline, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26024F0325?

260-Network Contract Office 20 (36C260) awarded 36C26024F0325 to Glaxosmithkline, LLC (potential $108K).

Who is the incumbent on 36C26024F0325?

Glaxosmithkline, LLC is the incumbent with $3.0B across 194 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2024.

When does Glaxosmithkline, LLC’s 36C26024F0325 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 28, 2024